◼ Archived
Business
🔮 holds ✓
We’re beating heart disease
The FDA has approved the first oral medication designed to replace injectable treatments for high cholesterol.
US FDA
3 independently sourced, verified news trends involving US FDA.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Jul 11, 2026 through Jul 27, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 holds ✓
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.
◼ Archived
Business
🔮 holds ✓
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.